Your browser doesn't support javascript.
SARS-CoV-2 vaccination and phase 1 cancer clinical trials.
Yap, Timothy A; Siu, Lillian L; Calvo, Emiliano; Lolkema, Martijn P; LoRusso, Patricia M; Soria, Jean-Charles; Plummer, Ruth; de Bono, Johann S; Tabernero, Josep; Banerji, Udai.
  • Yap TA; Investigational Cancer Therapeutics (Phase I Program), University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: tyap@mdanderson.org.
  • Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Calvo E; Early Phase Clinical Drug Development in Oncology, START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.
  • Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands.
  • LoRusso PM; Early Phase Clinical Trials Program, Yale University Medical Center, New Haven, CT, USA.
  • Soria JC; Department of Drug Development, Gustave Roussy Cancer Institute, University Paris Saclay, Villejuif, France.
  • Plummer R; Northern Institute for Cancer Care, Freeman Hospital and Newcastle University, Newcastle upon Tyne, UK.
  • de Bono JS; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.
  • Tabernero J; Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Banerji U; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.
Lancet Oncol ; 22(3): 298-301, 2021 03.
Article in English | MEDLINE | ID: covidwho-1371551
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / Clinical Trials, Phase I as Topic / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Neoplasms Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Lancet Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / Clinical Trials, Phase I as Topic / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Neoplasms Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Lancet Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article